NOS2 and type 1 diabetes mellitus: Indeed, the preliminary data from our laboratory demonstrated that chronic administration of 8-OH-DPAT suppresses the increase in pro-inflammatory mediators, tumor necrosis factor-alpha, interleukin-6, inducible-nitric oxide synthase and interleukin-1-beta in STZ-induced T1DM.